Synonyms: MDL 201053 | MDL-201053 | MDL201053 | Z-Phe-DL-Ala-fluoromethylketone | ZFA-fmk
Compound class:
Peptide
Comment: Z-FA-FMK is a modified di-peptide. It has been reported as a cathepsin B inhibtor [1], and antiviral activity against a variety of viruses has been reported [2].
SARS-CoV-2: In an HTS screening programme Z-FA-FMK was found to inhibit the 3CL protease (Mpro) of SARS-CoV-2 [3]. This inhibition translated to an antiviral effect with an EC50 of 130 nM. ![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
References |
1. Rajah T, Chow SC. (2015)
Suppression of Human T Cell Proliferation Mediated by the Cathepsin B Inhibitor, z-FA-FMK Is Due to Oxidative Stress. PLoS ONE, 10 (4): e0123711. [PMID:25915766] |
2. Roscow O, Ganassin R, Garver K, Polinski M. (2018)
Z-FA-FMK demonstrates differential inhibition of aquatic orthoreovirus (PRV), aquareovirus (CSRV), and rhabdovirus (IHNV) replication. Virus Res, 244: 194-198. [PMID:29174718] |
3. Zhu W, Xu M, Chen CZ, Guo H, Shen M, Hu X, Shinn P, Klumpp-Thomas C, Michael SG, Zheng W. (2020)
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-throughput Screening. ACS Pharmacol Transl Sci, [Epub ahead of print]. DOI: 10.1021/acsptsci.0c00108 |